WILLIAM SONNENBERG: Open Payments
NPI 1932173366 · TITUSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 33 payments from 12 companies in 2025. Trend: 2023 $696 · 2024 $545 · 2025 $738
Food & beverage: $738
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $186 |
| Otsuka America Pharmaceutical, Inc. | 4 | $150 |
| PFIZER INC. | 4 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $70 |
| Teva Pharmaceuticals USA, Inc. | 4 | $66 |
| Verona Pharma, Inc. | 3 | $51 |
| Lundbeck LLC | 3 | $51 |
| Lilly USA, LLC | 1 | $26 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: REXULTI, BREZTRI, CAPLYTA, AUSTEDO XR, ELIQUIS, Ohtuvayre, AIRSUPRA, MOUNJARO.
Industry payments across PA — which companies pay providers there.
